Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial"
Martedì 30 marzo 2021
circa 1 minuti di lettura
Journal and Affiliations:
Circulation, 30 marzo 2021
Marco Valgimigli, Cardiocentro Ticino, Lugano
Tags:
myocardial infarction
Authors:
Marco Valgimigli